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ABSTRACT 
Background: So far hepatocellular carcinoma (HCC) is the most common liver 
malignant tumour; it is rarely encountered on a healthy liver (9). The metastasis from 
HCC cancer are seen in lymph nodes (16%–40%) and lungs (34%–70%), (1,3,4,5,7,8), 
bone metastasis is unusual and some locations stay rare among them the skull 
(2,4,5). We report here a case of a patient operated in our department for skull 
metastasis. That patient was followed for hepatocellular carcinoma in digestive 
surgery department. 
Case presentation: The patient is a 57 years old male presenting HCC on healthy 
liver, the patient was referred to our department by digestive surgery colleagues to 
manage a parietal subcutaneous mass; brain CT scans were performed objectified a 
calvarial osteolytic process. We remove the tumour and we put a cranioplasty using 
surgical cement, later the histological studies were in favour of secondary location of 
hepatocellular carcinoma. 
Conclusion: Skull metastasis from hepatocellular carcinoma is rare, reporting such 
cases strengthen the idea of evoking HCC metastasis in the differential diagnosis of 
cranial subcutaneous mass.  
 
INTRODUCTION 
The development of hepatocellular carcinoma on a healthy liver is 
unusual and skull metastasis from this type of cancer is rare; this make 
evoking the diagnostic of a metastatic hepatocellular carcinoma for a 
skull lesion difficult, we report a case of skull metastatic lesion from a 
hepatocellular carcinoma on patient with a healthy liver.  
 
CASE PRESENTATION 
The patient is a male of 57 years old who presented weeks before he 
consulted an epigastric pain, then one month later a cranial left parietal 
subcutaneous mass. First an abdominal CT was performed objectified 
a tissue mass of 57 mm on the segment II of the liver extended to the 
gastro-hepatic omentum reaching the lesser curvature of the stomach, 
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 479 Skull metastasis of hepatocellular carcinoma in normal liver 
the surrounding hepatic tissue appeared to be 
normal; and all laboratory tests was initially normal. 
The patient was scheduled to a surgical resection 
meanwhile he was referred to our department to 
manage the cranial mass. The clinical exam at the 
admission found a conscious patient without 
neurological deficit presenting a left parietal mass 
with a diameter of 5 cm, soft, painless, fixed, pulsing, 
and without cutaneous defect. The brain CT 
objectified a tumor interesting the left parietal bone 
without cerebral invasion intensely enhanced after 
injection of the contrast product, on bony window 
the lesion is an irregular erosion measuring 48 x 53 
mm, (Figure 1). On the brain MRI the tumor was 
hypointense on T1 weighted images intensely 
enhanced by Gadolinium, the T2 weighted images 
have a heterogeneous signal, the angio-MRI images 
objectify a multiple thin vessels inside the tumor, 
there was a shift effect on the dura but there was no 
invasion to either dura or cutaneous tissues (Figure 
2). Bone scan with TC99m objectified a calvarial left 
parietal lake of fixation without any other skeleton 
locations. We operated the patient and we remove 
the lesion with the surrounding normal bone, it was 
a soft brown cauliflower-like mass highly 
vascularized, easily dissected from the cutaneous 
tissue pushing the dura witch was eroded at some 
spots, so we performed a dura plasty using a galea 
and a bone plasty using surgical cement to repair the 
bone defect. The histological study of the specimen 
found a predominance of pseudo glandular 
trabecular tissue and in the immunohistochemical 
examination there was a high expression of the 
hepatocyte antigen, so the diagnosis was in fact a 
secondary location of a fibro lamellar HCC. There 
was a full postoperative recovery. The patient was 
discharged from our department 7 days after the 
operation without any neurological deficits. We 
referred him back to general surgery where the liver 
tumor was resected with 2 cm of security marge and 
a portion of the stomach lesser curvature; the 
postoperative recovery was optimal. The patient is 
still followed in our external consultation since 24 
months and there is no tumor recurrence on brain 
CT scans. 
 
 
 
Figure 1: Preoperative brain CT scan. A: injected axial slide; B: bony window axial slide; C: sagittal bony window, showing an 
osteolytic left parietal lesion intensely enhanced after injection of the contrast product (red arrow). 
 
 
 
Figure 2: Preoperative brain MRI. A: T1 weighted imaging sagittal; B: T2 weighted imaging coronal; C: T1 enhanced; D: Angio MR, 
showing that the tumor is limited at skull plan without brain invasion and its hyper vasculazation nature 
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Figure 3: Preoperative brain CT. Bone plasty (red arrow), 
there is no tumor recurrence 
 
DISCUSSION 
So far hepatocellular carcinoma is the most frequent 
malignant liver tumor; the incidence in a healthy non 
cirrhotic liver is rare, according to different series it is 
between 1.7% and 14% (9). Skull metastasis are most 
commonly seen from breast, lung, prostate, and 
thyroid cancers (2, 4), metastasis from hepatic cancer 
is rare (5,2,4) it was reported in 0.5 to 1.6% of patients 
with HCC in most studies (3,4,1), in a review 
performed in 2014, a total of 59 patients with solitary 
skull metastasis from HCC were published (1).Males 
are largely more exposed to this affection than 
females (1,4).Metastases occurring in the calvarial 
site were more frequent than those occurring in the 
skull base and facial skeleton (1).The most common 
clinical presentation is a subcutaneous mass with 
occasional painful sensation (57%), followed by 
neurological deficits(51%), headache (15%) and 
seizure (3%) (1). The subcutaneous mass is usually 
firm solitary painless or occasionally painful rapidly 
evolving neglected by the patient (1,6,4,3). The tumor 
size and location are related to the neurologic deficit 
which is rather present in the skull base tumors 
(visual disturbance, dysphagia, deafness and facial 
numbness), than in the volt tumors where the 
weakness of the limbs is more frequent (4,5,7). 
Although rare cases of tumor bleeding were 
reported, the per operative hemorrhage risk should 
be kept in mind and preventive measures should not 
be neglect (2,3,4,6). In plane X rays the lesion appears 
to be osteolytic in all reported patients 
(1,2,3,4,5,6,7,8). The brain CT shows the bone defect, 
and a significant homogenous enhancement in all 
cases (1,4,5). In MRI the lesion appears as iso or hypo 
intense in T1 and T2 weighted images. The treatment 
for skull metastasis, includes radiotherapy, 
chemotherapy, surgery and palliative care. A single 
calvarial metastasis can be treated surgically (4). 
Although many reports suggest that the life 
expectancy is related to the liver failure and the 
presence of HCC skull metastasis don’t change it 
significantly (7); all studies suggest that the surgical 
treatment for HCC metastasis may relief the patient, 
esthetic, reduce the risks of neurological sequelae, 
and thus improve the quality of life (1,2,3,4,5). Pre-
operative embolisation is preferred (4). 
 
CONCLUSION 
Hepatocellular carcinoma (HCC) is responsible in 
rare reported cases of cranial metastasis, which 
clinical presentation is a subcutaneous mass and 
appears as an osteolytic lesion on radiological 
investigations. Although the vital prognostic is 
depending on the initial lesion, early diagnostic and 
surgical removal of the metastasis may improve the 
life quality.  
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